​

Solventum (SOLV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SOLV Stock Forecast

Solventum (SOLV) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $78.50, with a high of $82.00 and a low of $75.00. This represents a 5.67% increase from the last price of $74.29.

$50 $57 $64 $71 $78 $85 High: $82 Avg: $78.5 Low: $75 Last Closed Price: $74.29

SOLV Stock Rating

Solventum stock's rating consensus is Hold, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (25.00%), 2 Hold (50.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Hold
Total 4 0 1 2 1 Strong Sell Sell Hold Buy Strong Buy

SOLV Price Target Upside V Benchmarks

TypeNameUpside
StockSolventum5.67%
SectorHealthcare Stocks 23.68%
IndustryMedical Care Facilities Stocks13.82%

Price Target Trends

1M3M12M
# Anlaysts--6
Avg Price Target--$72.50
Last Closing Price$74.29$74.29$74.29
Upside/Downside---2.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25118-111
May, 25-19-111
Apr, 25-19-111
Mar, 25-19-111
Feb, 25-19-111
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 03, 2025Mizuho Securities$82.00$80.162.30%10.38%
Feb 28, 2025Wells Fargo$75.00$79.75-5.96%0.96%
Dec 03, 2024Steven ValiquetteMizuho Securities$70.00$72.28-3.15%-5.77%
Oct 07, 2024Rick WiseStifel Nicolaus$82.00$66.2923.70%10.38%
Oct 07, 2024Jason BednarPiper Sandler$71.00$67.744.81%-4.43%
Jul 15, 2024Patrick WoodMorgan Stanley$55.00$49.0012.24%-25.97%
May 30, 2024David RomanGoldman Sachs$54.00$59.72-9.58%-27.31%
Apr 09, 2024Patrick WoodMorgan Stanley$70.00$65.526.84%-5.77%
Apr 08, 2024Vik ChopraWells Fargo$69.00$70.06-1.51%-7.12%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 06, 2025KeyBancSector Weightinitialise
May 19, 2025Piper SandlerNeutralOverweightupgrade
Oct 07, 2024Piper SandlerNeutralinitialise
Sep 27, 2024BTIGNeutralNeutralhold
Sep 26, 2024Wolfe ResearchPeer Performinitialise
Sep 05, 2024BTIGNeutralinitialise
Jul 15, 2024Morgan StanleyEqual-WeightEqual-Weighthold
May 30, 2024Goldman SachsSellinitialise
Apr 09, 2024Morgan StanleyNeutralinitialise
Apr 09, 2024Morgan StanleyEqual-Weightinitialise

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.79$2.77----
Avg Forecast-$6.59$5.50$5.87$6.19$6.30
High Forecast-$6.62$5.76$6.35$6.26$6.37
Low Forecast-$6.57$5.23$5.29$6.13$6.23
Surprise %--57.97%----

Revenue Forecast

$8B $8B $8B $8B $9B $9B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.20B$8.25B----
Avg Forecast$8.20B$8.23B$8.26B$8.41B$8.48B$8.57B
High Forecast$8.27B$8.31B$8.33B$8.41B$8.48B$8.65B
Low Forecast$8.13B$8.22B$8.22B$8.40B$8.48B$8.50B
Surprise %-0.27%----

Net Income Forecast

$450M $630M $810M $990M $1B $1B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.35B$479.00M----
Avg Forecast-$1.14B$947.53M$1.00B$1.07B$1.09B
High Forecast-$1.14B$993.31M$1.09B$1.08B$1.10B
Low Forecast-$1.13B$901.75M$911.80M$1.06B$1.08B
Surprise %--57.89%----

SOLV Forecast FAQ

Is Solventum stock a buy?

Solventum stock has a consensus rating of Hold, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Solventum is a neutral investment for most analysts.

What is Solventum's price target?

Solventum's price target, set by 4 Wall Street analysts, averages $78.5 over the next 12 months. The price target range spans from $75 at the low end to $82 at the high end, suggesting a potential 5.67% change from the previous closing price of $74.29.

How does Solventum stock forecast compare to its benchmarks?

Solventum's stock forecast shows a 5.67% upside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the medical care facilities stocks industry (13.82%).

What is the breakdown of analyst ratings for Solventum over the past three months?

  • June 2025: 9.09% Strong Buy, 9.09% Buy, 72.73% Hold, 0% Sell, 9.09% Strong Sell.
  • May 2025: 0% Strong Buy, 9.09% Buy, 81.82% Hold, 0% Sell, 9.09% Strong Sell.
  • April 2025: 0% Strong Buy, 9.09% Buy, 81.82% Hold, 0% Sell, 9.09% Strong Sell.

What is Solventum’s EPS forecast?

Solventum's average annual EPS forecast for its fiscal year ending in December 2025 is $5.5, marking a 98.56% increase from the reported $2.77 in 2024. Estimates for the following years are $5.87 in 2026, $6.19 in 2027, and $6.3 in 2028.

What is Solventum’s revenue forecast?

Solventum's average annual revenue forecast for its fiscal year ending in December 2025 is $8.26B, reflecting a 0.10% increase from the reported $8.25B in 2024. The forecast for 2026 is $8.41B, followed by $8.48B for 2027, and $8.57B for 2028.

What is Solventum’s net income forecast?

Solventum's net income forecast for the fiscal year ending in December 2025 stands at $947.53M, representing an 97.81% increase from the reported $479M in 2024. Projections indicate $1B in 2026, $1.07B in 2027, and $1.09B in 2028.